Higher frequency of patients with ESCC having tumor stage I and IV showed EPAS1 DNA amplification, whereas the majority of the patients with ESCC having tumor stages II and III showed EPAS1 DNA deletion (p = 0.02). The gene discussed is EPAS1; the disease is neoplasm.